Abstract:Local anesthetics have been widely used for postoperative analgesia. However, multiple injections or local infiltration is required due to the short half-lives of local anesthetics after single injection, which results in poor compliance and increasing medical expense. In this study, an in situ forming gel (ISFG) based on lyotropic liquid crystal was developed to deliver bupivacaine hydrochloride (BUP) for long-acting postoperative analgesia. BUP-ISFG was designed to be administrated as a precursor solution which would spontaneously transform into gel with well-defined internal nanostructures for sustained drug release at the site of administration when exposed to physiological fluid. A lamellar-hexagonal-cubic phase transition occurred during the in situ gelation. The lamellar phase of the precursor solution endows it with low viscosity for good syringeability while the unique nanostructures of hexagonal and cubic phases of the in situ gel provide sustained drug release. Persistent analgesia effect in vivo was achieved with BUP-ISFG, and the plasma BUP concentration was found to be steadier compared to commercially available BUP for injection. In addition, the ISFG displayed acceptable biocompatibility and good biodegradability. The findings are positive about ISFG as a sustained release system for persistent postoperative analgesia. Statement of significance: To address the issue of insufficient postoperative analgesia associated with short half-lives of local anesthetics after single injection, an in situ forming gel (ISFG) based on lyotropic liquid crystal was developed to deliver bupivacaine hydrochloride (BUP) for postoperative analgesia over three days. The results demonstrated that persistent analgesia effect in vivo was achieved with single injection of BUP-ISFG, and the plasma BUP concentration was found to be steadier compared to commercially available BUP injection. The BUP-ISFG possessed a lamellar-hexagonal-cubic phase transition with corresponding crystal change in 3D nanostructure during the in situ gelation. The relationship between crystal nanostructure and carrier function, might provide some insights to the design and clinical applications of the drug delivery systems based on lyotropic liquid crystal.

Precision-guided long-acting analgesia by Gel-immobilized bupivacaine-loaded microsphere.

Achieving Long-Acting Local Analgesia Using an Intelligent Hydrogel Encapsulated with Drug and Ph Regulator.

Construction of bupivacaine‐loaded gelatin‐based hydrogel delivery system for sciatic nerve block in mice

Injectable in situ forming gel based on lyotropic liquid crystal for persistent postoperative analgesia

Mesoporous Silica Particles As a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy.

Extension Effect of Poly(Lactic-Co-Glycolic Acid)-Polyethylene Glycol Encapsulated Bupivacaine on Postoperative Neuroblockade in Cardiothoracic Surgery

Nanoparticle-Hydrogel: A Hybrid Biomaterial System for Localized Drug Delivery

A hybrid nanoparticle-protein hydrogel system for prolonged local anesthesia

Mussel-inspired Injectable Microbubbles Delivery System for Drug Ultrasound Contrast and Long-lasting Analgesic Effect in Peripheral Nerve Block

Porous Core/Dense Shell PLA Microspheres Embedded with High Drug Loading of Bupivacaine Crystals for Injectable Prolonged Release

A new long-acting analgesic formulation for postoperative pain management

Injectable Hydrogel Containing Bupivacaine-Loaded Mesoporous Silica Nanoparticles for Local Anesthetic Therapy

Preparation of ropivacaine-loaded mesoporous bioactive glass microspheres and evaluation of their efficacy for sciatic nerve block

Extended Release of Bupivacaine from Temperature-responsive Hydrogels Provides Multi-day Analgesia for Postoperative Pain

Sustainable release artifact in PLGA microspheres for prolonged local aesthetics in postoperative pain management

Long-term sciatic nerve block lead by supramolecular arrangement of self-delivery local anesthetic nano systems

Long-Term Synergistic Analgesic Effect Analysis of Co-Delivery Bupivacaine and Dexmedetomidine Loaded by Nano Multilayer Liposome

Construction of meloxicam and bupivacaine co-delivery nanosystem based on the pathophysiological environment of surgical injuries for enhanced postoperative analgesia

Synthesis of nanocapsules blended polymeric hydrogel loaded with bupivacaine drug delivery system for local anesthetics and pain management

An injectable oleogel-based bupivacaine formulation for prolonged non-opioid post-operative analgesia

A PLGA-PEG-PLGA Thermosensitive Gel Enabling Sustained Delivery of Ropivacaine Hydrochloride for Postoperative Pain Relief.